IGF2R and prostate carcinoma: Additionally, four novel targets were predicted (IGF2R, C5AR/C5AR1, RAB7, and SETD2) which are all involved in molecular pathways closely connected to prostate cancer, with some having been recently proposed as suitable targets for other types of cancers.